---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-082494"
form_type: "8-K"
ticker: "XENE"
cik: "0001582313"
company_name: "Xenon Pharmaceuticals Inc."
filed_at: "2025-06-05T23:59:59+00:00"
generated_at: "2026-05-19T21:52:44.462634+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Xenon Pharmaceuticals holds 2025 Annual Meeting; all director nominees elected

## Summary
- All 8 director nominees elected with over 64M votes each; broker non-votes of 2.2M.
- Advisory say-on-pay passed with 67.3M for, 2.1M against, 0.5M abstain.
- Appointment of PricewaterhouseCoopers LLP as auditor approved (72.0M for, 34K withheld).
- Auditor remuneration authority approved (72.0M for, 25K against, 11K abstain).
- Approximately 94.1% of outstanding common shares voted at the meeting.

## SEC filing metadata
- accession: 0000950170-25-082494
- form_type: 8-K
- ticker: XENE
- cik: 0001582313
- company_name: Xenon Pharmaceuticals Inc.
- filed_at: 2025-06-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1582313/000095017025082494/0000950170-25-082494-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1582313/000095017025082494/xene-20250604.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-082494
- JSON: https://secwatch.observer/filing/0000950170-25-082494.json
- Plain text: https://secwatch.observer/filing/0000950170-25-082494.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.